Investigation Overview
June 27, 2016 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Infinity Pharmaceuticals Inc. (NASDAQ:INFI) was announced over potential breaches of fiduciary duties by certain officers and directors at Infinity Pharmaceuticals. The investigation by a law firm concerns whether certain Infinity Pharmaceuticals directors breached their f...
You must register (for free) or login to view the entire investigation.